Healthy aging in women [Medical Post Q&A]

A Canadian study comparing high-dose raloxifene (150 rag) to continuous combined HRT (0.625 mg of Premarin and 2.5 mg of Provera) evaluates the effects of these treatments on endometrial thickness, uterine volume and histology in 135 postmenopausal women. At 12 months, a statistically significant in...

Full description

Saved in:
Bibliographic Details
Published inThe Medical post Vol. 35; no. 41; p. Q1
Main Authors McSherry, James, Yuen, Chui Kin, Brown, Jacques
Format Magazine Article
LanguageEnglish
Published Chicago EnsembleIQ 07.12.1999
Subjects
Aging
Breast cancer
Cardiovascular disease
Cardiovascular system
Clinical trials
Dementia
Disease prevention
Endometrium
Estrogens
Family medicine
Health care
Health sciences
Heart
Hormone replacement therapy
Lipids
Menopause
Older people
Osteoporosis
Physiological aspects
Uterus
Women
Womens health
Canada
Quebec Canada
Online AccessGet full text

Cover

More Information
Summary:A Canadian study comparing high-dose raloxifene (150 rag) to continuous combined HRT (0.625 mg of Premarin and 2.5 mg of Provera) evaluates the effects of these treatments on endometrial thickness, uterine volume and histology in 135 postmenopausal women. At 12 months, a statistically significant increase from baseline for endometrial thickness and uterine volume was observed in the HRT group, but not in the raloxifene group.
ISSN:0025-7435